BMTR

(redirected from Bone Marrow Transplant Recipient)
AcronymDefinition
BMTRBlood and Marrow Transplantation Reviews (journal)
BMTRBackup Memory Transfer (AT&T)
BMTRBone Marrow Transplant Recipient
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
The term hematopoietic stem cell transplant recipients (HSCT) is preferable to "bone marrow transplant recipients" because the new term more accurately describes the current state of transplantation, which may involve harvesting donor cells from peripheral blood, umbilical cord blood, or bone marrow (1).
The use of laminar air flow rooms for bone marrow transplant recipients has been controversial.
Preventing opportunistic infections in bone marrow transplant recipients. Transplant Infectious Disease 1999;1:40-9.
* Infusions of white blood cells called killer T cells can arm bone marrow transplant recipients against a virus that often causes deadly lung infections, researchers found (142: 21].
The multi-sport festival is directed at attracting organ, tissue and bone marrow transplant recipients, living donors, and donor families from across the US.
Bone marrow transplant recipients -- as well as patients who receive whole-organ transplants -- are at risk because they must take immunity-suppressing drugs to avoid rejecting their new grafts.
Riddell and his colleagues report in the July 10 SCIENCE that the cell infusions boosted the bone marrow transplant recipients' ability to kill CMV-infected cells.
Astellas says the approval of Mycamine was based on 32 global studies conducted in 2,402 subjects who had confirmed, or were at risk for, Candida fungal infections, including patients with hematologic malignancies, bone marrow transplant recipients, and HIV-positive patients.
Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial.
Subjects in the Mycamine studies included a broad range of individuals who had a confirmed, or were at risk for, candida fungal infections, including patients with hematologic malignancies, bone marrow transplant recipients, and HIV-positive patients.
Apergillosis is a life-threatening fungal infection in high-risk patient populations, especially organ and bone marrow transplant recipients, cancer patients, and patients with HIV/AIDS.
dubliniensis fungemia have been reported from Europe, all in HIV-negative bone marrow transplant recipients with chemotherapy-induced neutropenia (8).
Full browser ?